Table 6.
Independent predictors of survival after TACE as evaluated by multivariable analysis using the Cox proportional hazards model
| HR | 95% CI | p value | |
|---|---|---|---|
| mHAP-III (per class) | 1.31 | 1.10–1.55 | 0.000 |
| Age-tv (per 1 year) | 1.02 | 1.01–1.03 | 0.003 |
| Alcoholic etiology | 1.26 | 1.02–1.57 | 0.037 |
| Radiologic response | |||
| Complete response | Ref. | ||
| Partial response | 1.87 | 1.45–2.41 | 0.000 |
| Stable disease | 1.99 | 1.29–3.07 | 0.002 |
| Progressive disease | 2.81 | 2.09–3.78 | 0.000 |
| Main post-TACE treatment (curative) | 0.44 | 0.33–0.59 | 0.000 |
TACE, transarterial chemoembolization; mHAP-III, modified hepatoma arterial embolization III; HR, hazard ratio; CI, confidence interval; tv, time-varying variable; main post-TACE treatment, patients who underwent liver transplantation, ablation, or surgery after TACE.